<< Back
Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders

SAN DIEGO--(BUSINESS WIRE)--May. 8, 2012-- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will webcast its Annual Meeting of Stockholders on Tuesday, May 15, 2012 at 9:00 a.m. PT/ 12:00 p.m. ET from the Company's corporate headquarters in San Diego. Following the Annual Meeting, Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals, will provide a corporate overview.

The call will be webcast live through the "Investors" section of Amylin's corporate website and a recording will be made available following the close of the call. To access the webcast, please log on to www.amylin.com approximately 15 minutes prior to the call to register, download and install any necessary audio software. For those without access to the Internet, the live call may be accessed by phone by calling (888) 989-4344 (U.S./Canada) or (312) 470-7140 (international), participant passcode number 7994841. A replay of the call will also be available by phone beginning approximately two hours after the close of the call and can be accessed at (800) 388-5290 (U.S./Canada) or (203) 369-3692 (international).

About Amylin Pharmaceuticals
Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines. Amylin is committed to delivering novel therapies that transform the way diabetes and other metabolic disorders are treated. Amylin is headquartered in San Diego, Calif., and has a commercial manufacturing facility in Ohio. More information on Amylin Pharmaceuticals is available at www.amylin.com.

Source: Amylin Pharmaceuticals, Inc.

Amylin Pharmaceuticals, Inc.
Investors
Christine Everett-Zedelmayer
(858) 458-8517
christine.everett@amylin.com
or
Media
Alice Izzo
(858) 642-7272
alice.izzo@amylin.com

Could not find file '\\aws.nasdaqomx.com\irweb\content3\IRXMLDATA\10\101911\Disclaimers.xml'.